# Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

Study · id `cardio:ct-nct01561222` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01561222](<https://clinicaltrials.gov/study/NCT01561222>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01561222

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT01561222. Randomized; double masking; primary purpose prevention. Start 2015-07 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT01561222, source copy `cardio:ctgov-nct01561222-2015-06-08`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT01561222, source copy `cardio:ctgov-nct01561222-2015-06-08`, retrieved 2026-10-26)
- Primary completion: 2016-03 (anticipated) (ClinicalTrials.gov record NCT01561222, source copy `cardio:ctgov-nct01561222-2015-06-08`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT01561222, source copy `cardio:ctgov-nct01561222-2015-06-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01561222-2015-06-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
- Condition: Chronic Kidney Disease Stage 1
- Condition: Chronic Kidney Disease Stage 2
- Intervention (Drug): Calcitriol
- Intervention (Drug): placebo
- Lead sponsor: Taixing People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: b75e56ff586f4da7f51f0b1077cfbb8fa38e90da846524e7223a1a6384a8c6f5
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
